Multiple Benign Symmetric Lipomatosis—A Differential Diagnosis of Obesity. Is There a Rationale for Fibrate Treatment?
暂无分享,去创建一个
[1] F. Gonzalez,et al. Suppression of expression of muscle-associated proteins by PPARalpha in brown adipose tissue. , 2005, Biochemical and biophysical research communications.
[2] J. Armario‐Hita,et al. Benign symmetric lipomatosis (Launois–Bensaude syndrome) , 2005, International journal of dermatology.
[3] E. Nisoli,et al. Multiple symmetric lipomatosis may be the consequence of defective noradrenergic modulation of proliferation and differentiation of brown fat cells , 2002, The Journal of pathology.
[4] G. Enzi,et al. Multiple symmetric lipomatosis: clinical aspects and outcome in a long-term longitudinal study , 2002, International Journal of Obesity.
[5] A. Kovács,et al. [Madelung disease. A case report with special reference to therapy]. , 1997, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[6] C. Klein,et al. Madelung-Krankheit Eine Fallbeschreibung mit besonderer Berücksichtigung der Therapie , 1997, Der Chirurg.
[7] C. Zancanaro,et al. Multiple symmetric lipomatosis. Ultrastructural investigation of the tissue and preadipocytes in primary culture. , 1990, Laboratory investigation; a journal of technical methods and pathology.
[8] M. Pollock,et al. NEUROPATHY IN MULTIPLE SYMMETRIC LIPOMATOSIS , 1988 .
[9] T. Peters,et al. MULTIPLE SYMMETRIC LIPOMATOSIS (LAUNOIS‐BENSAUDE SYNDROME): EFFECT OF ORAL SALBUTAMOL , 1987, Clinical endocrinology.